utritional supplementation in patient with cirrhosis of liver
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2021/03/032164
- Lead Sponsor
- Max Super Speciality Hospital Vaishali
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1-Patients diagnosis with cirrhosis of liver.
2-Patients who are taking/ who are not taking BCCA supplementation
Exclusion Criteria
1-Patients on dietary protein restriction
2-Serum total bilirubin of 3 mg/ dl or higher
3-Hepatocellular carcinoma
4-Resistant ascites
5-Oesohageal varices
6-Hepato encephalopathy grade III or higher
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-Any improvement in the serum albumin, pre-albumin levels and clinical nutritional parameters. <br/ ><br>2-Occurrence of event free survival- <br/ ><br>-any occurrence of the following during the course of the disease like <br/ ><br>a-Hepato encephalopathy <br/ ><br>b-Variceal bleed <br/ ><br>c-Spontaneous bacterial peritonitis <br/ ><br>d-Hepato renal syndrome <br/ ><br>e-Death <br/ ><br>3-Improvement in the Quality of life assessed by SF-36Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method -Would be determined on basis of child pug score and MELD score at base line and during follow up <br/ ><br>-Number of hospital admissions during the course of follow up <br/ ><br>-duration of hospital stay for the management of any liver related complications. <br/ ><br>-Overall mortality/survival <br/ ><br>Timepoint: 12 months